FINANCIAL STATEMENTS 182 ASTRAZENECA ANNUAL REPORT AND FORM 20-F INFORMATION 2007 NOTES TO THE COMPANY FINANCIAL STATEMENTS CONTINUED 5 RESERVES Share Capital Pro t premium redemption Other and loss 2007 2006 account reserve reserves account Total Total $m $m $m $m $m $m At beginning of year 1,671 71 1,841 15,480 19,063 23,778 Profit for the year 9,407 9,407 652 Dividends 2,658 2,658 2,217 Cash flow hedge in anticipation of debt issue 21 21 Share re-purchases 20 4,170 4,150 4,129 Share premiums 217 217 979 At end of year 1,888 91 1,841 18,038 21,858 19,063 Distributable reserves at end of year 1,841 13,978 15,819 6,063 As permitted by section 230 of the Companies Act 1985, the Company has not presented its profit and loss account.
At 31 December 2007 $4,060m 31 December 2006 $11,129m of the profit and loss account reserve was not available for distribution.
The majority of this non-distributable amount relates to profit arising on the sale of Astra AB to a subsidiary in 1999, which becomes distributable as the underlying receivable is settled.
During 2007, $7,069m 2006: $5,738m of the profit was realised by repayment.
Subsequent to the year end, a further $377m was repaid on 18 January 2008, resulting in additional distributable reserves not included in the figures above.
Included in other reserves is a special reserve of $157m, arising on the redenomination of share capital in 1999.
6 RECONCILIATION OF MOVEMENT IN SHAREHOLDERS FUNDS 2007 2006 $m $m Shareholders funds at beginning of year 19,446 24,173 Net profit for the financial year 9,407 652 Dividends 2,658 2,217 Cash flow hedge in anticipation of debt issue 21 Issues of AstraZeneca PLC Ordinary Shares 218 985 Re-purchase of AstraZeneca PLC Ordinary Shares 4,170 4,147 Net increase reduction in shareholders funds 2,776 4,727 Shareholders funds at end of year 22,222 19,446 7 SHARE CAPITAL Authorised Allotted, called-up and fully paid 2007 2007 2006 $m $m $m Issued Ordinary Shares $0.25 each 364 364 383 Unissued Ordinary Shares $0.25 each 236 Redeemable Preference Shares 1 each 50,000 600 364 383 The total authorised number of Ordinary Shares at 31 December 2007 was 2,400,000,000, of which 1,457,000,853 Ordinary Shares were in issue.
The Redeemable Preference Shares carry limited class voting rights and no dividend rights.
This class of shares is capable of redemption at par at the option of the Company on the giving of seven days written notice to the registered holder of the shares.
The movements in share capital during the year can be summarised as follows: No.
of shares million $m At 1 January 2007 1,532 383 Issues of shares 5 1 Re-purchase of shares 80 20 At 31 December 2007 1,457 364
